Similar articles for PMID: 32878769

Year	Number of Results
1996	1
1999	1
2004	1
2008	1
2009	2
2010	1
2011	1
2012	3
2013	5
2014	6
2015	10
2016	9
2017	9
2018	12
2019	26
2020	23
2021	12
2022	11
2023	3
2024	0

1

The Role of the Microbiome in Cancer and Therapy Efficacy: Focus on Lung Cancer.

Halley A, Leonetti A, Gregori A, Tiseo M, Deng DM, Giovannetti E, Peters GJ. Halley A, et al. Anticancer Res. 2020 Sep;40(9):4807-4818. doi: 10.21873/anticanres.14484. Anticancer Res. 2020. PMID: 32878769 Review.

2

Gut Microbiota in Lung Cancer: Where Do We Stand?

Georgiou K, Marinov B, Farooqi AA, Gazouli M. Georgiou K, et al. Int J Mol Sci. 2021 Sep 27;22(19):10429. doi: 10.3390/ijms221910429. Int J Mol Sci. 2021. PMID: 34638770 Free PMC article. Review.

3

Commensal microbiota contributes to predicting the response to immune checkpoint inhibitors in non-small-cell lung cancer patients.

Zhang C, Wang J, Sun Z, Cao Y, Mu Z, Ji X. Zhang C, et al. Cancer Sci. 2021 Aug;112(8):3005-3017. doi: 10.1111/cas.14979. Epub 2021 Jun 23. Cancer Sci. 2021. PMID: 34028936 Free PMC article.

4

Characterisation of gut, lung, and upper airways microbiota in patients with non-small cell lung carcinoma: Study protocol for case-control observational trial.

Bingula R, Filaire M, Radosevic-Robin N, Berthon JY, Bernalier-Donadille A, Vasson MP, Thivat E, Kwiatkowski F, Filaire E. Bingula R, et al. Medicine (Baltimore). 2018 Dec;97(50):e13676. doi: 10.1097/MD.0000000000013676. Medicine (Baltimore). 2018. PMID: 30558074 Free PMC article. Clinical Trial.

5

Role of antibiotic use, plasma citrulline and blood microbiome in advanced non-small cell lung cancer patients treated with nivolumab.

Ouaknine Krief J, Helly de Tauriers P, Dumenil C, Neveux N, Dumoulin J, Giraud V, Labrune S, Tisserand J, Julie C, Emile JF, Chinet T, Giroux Leprieur E. Ouaknine Krief J, et al. J Immunother Cancer. 2019 Jul 10;7(1):176. doi: 10.1186/s40425-019-0658-1. J Immunother Cancer. 2019. PMID: 31292005 Free PMC article.

6

A repository of microbial marker genes related to human health and diseases for host phenotype prediction using microbiome data.

Han W, Ye Y. Han W, et al. Pac Symp Biocomput. 2019;24:236-247. Pac Symp Biocomput. 2019. PMID: 30864326 Free PMC article.

7

Gut microbiome and response to checkpoint inhibitors in non-small cell lung cancer-A review.

Nagasaka M, Sexton R, Alhasan R, Rahman S, Azmi AS, Sukari A. Nagasaka M, et al. Crit Rev Oncol Hematol. 2020 Jan;145:102841. doi: 10.1016/j.critrevonc.2019.102841. Epub 2019 Dec 23. Crit Rev Oncol Hematol. 2020. PMID: 31884204 Review.

8

Chemotherapy-induced immunomodulation in non-small-cell lung cancer: a rationale for combination chemoimmunotherapy.

Zheng H, Zeltsman M, Zauderer MG, Eguchi T, Vaghjiani RG, Adusumilli PS. Zheng H, et al. Immunotherapy. 2017 Sep;9(11):913-927. doi: 10.2217/imt-2017-0052. Immunotherapy. 2017. PMID: 29338609 Free PMC article. Review.

9

The use of combination immunotherapies as front-line therapy for non-small-cell lung cancer.

Santana-Davila R, Chow LQ. Santana-Davila R, et al. Future Oncol. 2018 Feb;14(3):191-194. doi: 10.2217/fon-2017-0124. Epub 2018 Jan 16. Future Oncol. 2018. PMID: 29334785 Free article. No abstract available.

10

Human Lung Microbiome on the Way to Cancer.

Kovaleva OV, Romashin D, Zborovskaya IB, Davydov MM, Shogenov MS, Gratchev A. Kovaleva OV, et al. J Immunol Res. 2019 Jul 29;2019:1394191. doi: 10.1155/2019/1394191. eCollection 2019. J Immunol Res. 2019. PMID: 31485458 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

122 results

Results by year